|
RNASEH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.481600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.559580E-01 |
| Normal-vs-Stage2 |
9.412300E-02 |
| Normal-vs-Stage3 |
1.790200E-02 |
| Normal-vs-Stage4 |
1.777380E-01 |
| Stage1-vs-Stage2 |
3.830200E-01 |
| Stage1-vs-Stage3 |
1.463000E-01 |
| Stage1-vs-Stage4 |
6.454600E-01 |
| Stage2-vs-Stage3 |
8.345200E-01 |
| Stage2-vs-Stage4 |
7.555800E-01 |
| Stage3-vs-Stage4 |
5.511000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.259790E-02 |
| Normal-vs-AfricanAmerican |
4.024000E-01 |
| Normal-vs-Asian |
1.333590E-01 |
| Caucasian-vs-AfricanAmerican |
5.271400E-01 |
| Caucasian-vs-Asian |
2.001600E-02 |
| AfricanAmerican-vs-Asian |
5.217700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.637500E-03 |
| Normal-vs-Female |
3.198600E-01 |
| Male-vs-Female |
1.333390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.191600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.537900E-02 |
| Normal-vs-Age(61-80Yrs) |
9.099900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.422600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.814000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.873000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.824000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.195800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.703000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.841200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.540200E-01 |
| Normal-vs-Grade 2 |
2.731500E-02 |
| Normal-vs-Grade 3 |
3.170300E-02 |
| Normal-vs-Grade 4 |
4.322600E-01 |
| Grade 1-vs-Grade 2 |
2.420600E-01 |
| Grade 1-vs-Grade 3 |
2.723200E-01 |
| Grade 1-vs-Grade 4 |
5.198200E-01 |
| Grade 2-vs-Grade 3 |
9.289200E-01 |
| Grade 2-vs-Grade 4 |
5.127000E-01 |
| Grade 3-vs-Grade 4 |
4.693800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.515650E-01 |
| Normal-vs-ccB subtype |
1.372200E-01 |
| ccA subtype-vs-ccB subtype |
8.725200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.882200E-02 |
| Normal-vs-N1 |
6.884800E-01 |
| N0-vs-N1 |
1.955770E-01 |
|
|
